colchicine has been researched along with Disease Exacerbation in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (6.67) | 18.2507 |
2000's | 18 (30.00) | 29.6817 |
2010's | 25 (41.67) | 24.3611 |
2020's | 13 (21.67) | 2.80 |
Authors | Studies |
---|---|
Berkun, Y; Biro, O; Dor-Wollman, T; Eisenstein, EM; Gileles-Hillel, A | 1 |
Alogna, A; El-Shafeey, M; Elsanhoury, A; Fechner, H; Kühl, U; Lin, J; Pappritz, K; Schulz, R; Spillmann, F; Tschöpe, C; Van Linthout, S | 1 |
Avanoglu Guler, A; Bilici, R; Coskun, C; Goker, B; Haznedaroglu, S; Karadeniz, H; Kasifoglu, T; Kucuk, H; Ozturk, MA; Sari, I; Satis, H; Tufan, A; Yildirim, D; Yuce Inel, T | 1 |
Ali, Z; Anand, SS; Avezum, A; Bangdiwala, SI; Belley-Cote, EP; Berwanger, O; Bosch, J; Choudhri, S; Dans, AL; Eikelboom, JW; Farkouh, ME; Felix, C; Harper, W; Hassany, M; Heenan, L; Jolly, SS; Kontsevaya, A; Loeb, M; Lopes, RD; Lopez-Jaramillo, P; Pais, P; Palileo-Villanueva, LM; Rangarajan, S; Sharma, SK; Tarhuni, WM; Wasserman, S; Whitlock, RP; Xavier, D; Xu, L; Yusuf, S; Yusufali, A | 1 |
Almas, A; Anand, SS; Avezum, A; Bangdiwala, SI; Belley-Cote, EP; Berwanger, O; Bosch, J; Choudhri, S; Diaz, R; Drapkina, O; Eikelboom, JW; Farkouh, ME; Felix, C; Harper, W; Hassany, M; Heenan, L; Jolly, SS; Kumar Sharma, S; Loeb, M; Lopes, RD; Lopez-Jaramillo, P; Luz Diaz, M; Rangarajan, S; Tarhuni, WM; Wasserman, S; Whitlock, RP; Xu, L; Yusuf, S; Yusufali, A | 1 |
Aktaş, İ; Altıntaş Meşe, C; Çakan, M; Otar Yener, G | 1 |
Schectman, JM | 1 |
Cornel, JH; Eikelboom, JW; Fiolet, ATL; Heijman, MWJ; Mosterd, A; Nidorf, SM; Popa, CD; Schut, A; Thompson, PL; Tijssen, JGP; van den Bemt, BJF; van den Ende, CHM | 1 |
Armagan, B; Atas, N; Babaoglu, H; Bilge, NSY; Bodakci, E; Goker, B; Haznedaroglu, S; Kalyoncu, U; Kasifoglu, T; Kilic, L; Ozturk, MA; Salman, RB; Sari, A; Satis, H; Tufan, A; Yardımcı, GK | 1 |
Barbas, C; Cecconi, A; Godzien, J; Ibañez, B; Izidoro, MA; López-Gonzálvez, Á; Mateo, J; Panadero, MI; Ruiz-Cabello, J; Rupérez, FJ; Vilchez, JP | 1 |
Dalbeth, N; Donovan, P; Robinson, PC | 1 |
Alexopoulos, D; Angelidis, C; Baltagiannis, S; Cleman, M; Dangas, G; Davlouros, P; Deftereos, SG; Dolianitis, K; Gargalianos, P; Gerakari, S; Giannopoulos, G; Giotaki, SG; Gogos, C; Goudevenos, J; Hahalis, G; Iliodromitis, E; Kanonidis, I; Katritsis, D; Kolettis, T; Kotanidou, A; Koulouris, NG; Manolis, AS; Martinèz-Dolz, L; Mehran, R; Metallidis, S; Michalis, L; Migdalis, I; Milionis, H; Naka, KK; Olympios, CD; Panagopoulos, P; Pyrgakis, VN; Randou, E; Reimers, B; Sianos, G; Siasos, GD; Sipsas, N; Stefanadis, C; Stefanini, GG; Syrigos, K; Tousoulis, D; Toutouzas, KP; Triposkiadis, F; Tsagalou, E; Tsiodras, S; Tsioufis, K; Tsoukalas, G; Vavouranakis, E; Vrachatis, DA | 1 |
Ahmadi, M; Askari, VR; Baradaran Rahimi, V; Gholoobi, A; Naghedinia, H; Vakili, V | 1 |
Chakraborty, B; Chowbay, B; Haaland, B; Huebner, JL; Kraus, VB; Leung, YY; Tan, MH; Thumboo, J; Tjai, M; Wang, C; Wong, SBS | 1 |
Amarilyo, G; Brik, R; Butbul-Aviel, Y; Hezkelo, N; Uziel, Y | 1 |
Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV | 1 |
Bonetto, V; Carra, S; Cereda, C; Ceroni, M; Chio, A; Crippa, V; D'Agostino, VG; D'Amico, R; Gessani, A; Mandrioli, J; Monsurrò, MR; Poletti, A; Provenzani, A; Riva, N; Sabatelli, M; Silani, V; Simone, IL; Sorarù, G; Zucchi, E | 1 |
Jamil, H; Khawla, K; Moez, J; Raida, BS; Saida, G; Sameh, M; Yosra, C; Zouhir, B | 1 |
Eikelboom, JW; Nidorf, SM; Thompson, PL | 1 |
Ching, JK; Ju, JS; Margeta, M; Pittman, SK; Weihl, CC | 1 |
Cheetham, TC; Levy, GD; Niu, F; Rashid, N | 1 |
Federman, DG; Galen, BT | 1 |
Aubert, JP; Delva, C; Ea, HK; Guggenbuhl, P; Lambert, C; Lancrenon, S; Lanz, S; Lioté, F; Pascart, T; Saraux, A | 1 |
Ben-Chetrit, E; Hayrapetyan, H; Sarkisian, T; Shahsuvaryan, G | 1 |
Matsuyoshi, T | 1 |
Bonilla-Abadía, F; Cañas, CA; Suso, JP; Tobón, GJ; Vernaza-Pizarro, A; Zuñiga-Velásquez, A | 1 |
Han, SJ; Kim, JH; Kim, JI; Park, KM | 1 |
Basso, D; Burlando, M; Cimmino, MA; Cozzani, E; Drago, F; Larosa, M; Parodi, A; Rongioletti, F | 1 |
Stamp, LK | 1 |
Agarwal, GG; Asthana, A; Das, SK; Goel, G; Srivastava, R | 1 |
Asial, R; Boente, Mdel C; Happle, R; Nadra, G | 1 |
Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A | 1 |
Bonder, A; Bonis, PA; Kaplan, MM; Ruthazer, R | 1 |
Graser, E; Pope, RS; Zychowicz, ME | 1 |
El-Zawawy, H; Mandell, BF | 1 |
Kojima, N; Misawa, Y; Ohki, S; Sakano, Y | 1 |
Cacoub, P; Geri, G | 1 |
Aktas, A; Engin, RI; Eren, YB; Karakuzu, A; Karatay, S; Kiziltunc, A; Yildirim, K | 1 |
Livneh, A | 1 |
Elhan, AH; Erdogan, BD; Özçakar, ZB; Yalçinkaya, F | 1 |
Ates, K; Civriz, S; Ensari, A; Karatan, O; Kutlay, S; Nergizoglu, G | 1 |
Kaymak, B; Köklü, S; Kuran, S; Ozçakar, L; Sakaoğullari, Z | 1 |
Angulo, P; Lindor, KD | 1 |
Kalunian, KC; Wu, CW | 1 |
Pouchot, J; Vinceneux, P | 1 |
Froment, R; Radisic, M; Santamarina, J | 1 |
Cottin, V | 1 |
Basugi, A; Ikusaka, M; Itoga, S; Kim, S; Mikasa, G; Nishizawa, S; Nomura, F; Ohira, Y; Sunaga, M | 1 |
Apak, H; Arisoy, N; Bilgen, H; Celkan, T; Demirel, A; Kasapcopur, O; Ozkan, A; Yildiz, I | 1 |
Brownell, I; Franks, AG; Soter, NA | 1 |
Announ, N; Guerne, PA | 1 |
Chen, GS; Lan, CC; Lu, YW; Tsai, J; Wu, CS | 1 |
Dinarello, CA; Kaplan, MM; McKusick, AF; Miller, LC; Sharma, A; Tassoni, JP | 1 |
el Nahas, AM; Zhang, G | 1 |
Kaplan, MM | 1 |
Rockey, DC | 1 |
Fradin, Z; Mittelman, M; Sender, BZ; Yarmolovsky, A; Zeidman, A | 1 |
Aksentijevich, I; Kastner, DL; Koziol, DE; Langevitz, P; Livneh, A; Pras, E; Pras, M; Shinar, Y; Zaks, N | 1 |
Karagezian, KG; Nazaretian, EE; Ovnanian, KO; Zavrodniaia, AM | 1 |
Ben Ghorbel, I; Feki, M; Houman, H; Khanfir, M; Lamloum, M; Mebazaa, A; Miled, M | 1 |
11 review(s) available for colchicine and Disease Exacerbation
Article | Year |
---|---|
Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Cholesterol; Colchicine; Crystallization; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Macrophages; Molecular Targeted Therapy; Neutrophils; Plaque, Atherosclerotic; Secondary Prevention | 2014 |
Major unanswered questions in the clinical gout field.
Topics: Allopurinol; Benzbromarone; Colchicine; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Patient Care Planning; Probenecid; Renal Insufficiency, Chronic; Uric Acid; Uricosuric Agents | 2017 |
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Disease Progression; Early Diagnosis; Humans; Hypertension; Hypoalbuminemia; Kidney Failure, Chronic; Male; Mesalamine; Proteinuria; Rare Diseases; Renal Dialysis; Risk Factors; Time Factors | 2009 |
Managing gout: how is it different in patients with chronic kidney disease?
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; Risk Factors; Thiazoles | 2010 |
[What's new in recurrent pericarditis in 2011?].
Topics: Acute Disease; Algorithms; Aspirin; Colchicine; Disease Progression; Humans; Pericarditis; Recurrence; Standard of Care | 2011 |
Management of primary biliary cirrhosis and autoimmune cholangitis.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Cholangitis; Colchicine; Disease Progression; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Penicillamine; Ursodeoxycholic Acid | 1998 |
New developments in osteoarthritis.
Topics: Acetaminophen; Acupuncture Therapy; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Chondroitin; Colchicine; Disease Progression; Glucosamine; Gout Suppressants; Humans; Osteoarthritis; Radiography; Synovial Membrane | 2005 |
[From familial Mediterranean fever to amyloidosis].
Topics: Acute Disease; Amyloidosis; Colchicine; Disease Progression; Familial Mediterranean Fever; Gout Suppressants; Humans; Prognosis | 2005 |
[Idiopathic interstitial pneumonia: treatment].
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors | 2006 |
The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
Topics: Adjuvants, Immunologic; Cholagogues and Choleretics; Colchicine; Disease Progression; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Methotrexate; Ursodeoxycholic Acid | 1997 |
Hepatic fibrogenesis and hepatitis C.
Topics: Adrenal Cortex Hormones; Animals; Biopsy; Cells, Cultured; Colchicine; Disease Progression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Retinoids | 2000 |
10 trial(s) available for colchicine and Disease Exacerbation
Article | Year |
---|---|
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
Topics: Aspirin; Canada; Colchicine; COVID-19; Disease Progression; Humans; SARS-CoV-2; Thrombosis; Treatment Outcome | 2022 |
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
Topics: Adolescent; Adult; Aspirin; Canada; Colchicine; COVID-19 Drug Treatment; Disease Progression; Humans; Oxygen; Rivaroxaban; Treatment Outcome | 2022 |
In high-risk outpatients with COVID-19, neither colchicine nor aspirin reduced disease progression or death at 45 d.
Topics: Aspirin; Colchicine; COVID-19; Disease Progression; Humans; Outpatients; Treatment Outcome | 2023 |
Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements : Exploratory Analyses From a Randomized, Controlled, Double-Blind Trial.
Topics: Arthroplasty, Replacement, Hip; Australia; Colchicine; Disease Progression; Double-Blind Method; Humans; Incidence; Osteoarthritis; Osteoarthritis, Knee | 2023 |
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Betacoronavirus; C-Reactive Protein; Cause of Death; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diarrhea; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Greece; Hospitalization; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Time Factors; Treatment Outcome; Troponin; Tubulin Modulators | 2020 |
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Non-ST Elevated Myocardial Infarction | 2021 |
Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Colchicine; Cytokines; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inflammation; Male; Middle Aged; Osteoarthritis, Knee; Synovial Fluid; Treatment Outcome; Young Adult | 2018 |
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Atrophy; Biopsy; Carcinoma, Squamous Cell; Colchicine; Disease Progression; Female; Forearm; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2018 |
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Autophagy; Biomarkers; Clinical Trials, Phase II as Topic; Colchicine; Disease Progression; DNA-Binding Proteins; Double-Blind Method; Female; Heat-Shock Proteins; HSP20 Heat-Shock Proteins; Humans; Male; Middle Aged; Molecular Chaperones; Motor Neurons; Neuroprotective Agents; Proteostasis; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2019 |
Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
Topics: Adult; Aged; Alkaline Phosphatase; Bilirubin; Colchicine; Disease Progression; Double-Blind Method; Female; Humans; Interleukin-1; Leukocyte Count; Leukocytes, Mononuclear; Liver; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Staphylococcus epidermidis | 1995 |
39 other study(ies) available for colchicine and Disease Exacerbation
Article | Year |
---|---|
Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings.
Topics: Adolescent; Child; Colchicine; Disease Progression; Familial Mediterranean Fever; Fever; Humans; Pyrin; Siblings; Surveys and Questionnaires | 2022 |
Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis.
Topics: Animals; Colchicine; Disease Progression; Humans; Inflammasomes; Mice; Myocarditis; NLR Family, Pyrin Domain-Containing 3 Protein | 2022 |
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.
Topics: Arthritis; Colchicine; COVID-19; Disease Progression; Familial Mediterranean Fever; Female; Fever; Humans; Male | 2023 |
Does having MEFV gene sequence variants affect the clinical course and colchicine response in children with PFAPA syndrome?
Topics: Adrenal Cortex Hormones; Child; Colchicine; Disease Progression; Familial Mediterranean Fever; Fever; Humans; Lymphadenitis; Lymphadenopathy; Pharyngitis; Pyrin; Retrospective Studies; Stomatitis, Aphthous | 2023 |
Familial Mediterranean fever-associated infertility and underlying factors.
Topics: Adult; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Genotype; Homozygote; Humans; Infertility; Logistic Models; Male; Middle Aged; Mutation; Pyrin; Risk Factors; Severity of Illness Index; Turkey | 2020 |
Plasma Metabolic Signature of Atherosclerosis Progression and Colchicine Treatment in Rabbits.
Topics: Animals; Atherosclerosis; Colchicine; Dietary Fats; Disease Models, Animal; Disease Progression; Humans; Metabolomics; Rabbits; Random Allocation | 2020 |
Cost-Effectiveness of Colchicine Prophylaxis for Gout Flares When Commencing Allopurinol.
Topics: Allopurinol; Australia; Colchicine; Cost-Benefit Analysis; Disease Progression; Drug Costs; Gout; Gout Suppressants; Humans; Quality-Adjusted Life Years; Time Factors; Treatment Outcome; United States | 2021 |
Is palindromic rheumatism amongst children a benign disease?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Arthritis, Rheumatoid; Child; Child, Preschool; Colchicine; Cross-Sectional Studies; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Israel; Male; Retrospective Studies | 2018 |
[Renal amyloidosis complicating adult onset Still's disease: about three cases].
Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Biopsy, Needle; Colchicine; Disease Progression; Female; Humans; Kidney Failure, Chronic; Methotrexate; Middle Aged; Nephrotic Syndrome; Renal Insufficiency; Still's Disease, Adult-Onset | 2019 |
Increased autophagy accelerates colchicine-induced muscle toxicity.
Topics: Animals; Autophagy; Colchicine; Disease Progression; Humans; Lysosomal Storage Diseases; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; Phagosomes; Simvastatin; Up-Regulation; Vacuoles | 2013 |
Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Databases, Factual; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Uric Acid | 2014 |
Large tophi and nodal arthritis.
Topics: Aged; Allopurinol; Colchicine; Comorbidity; Disease Progression; Gout; Gout Suppressants; Hand Joints; Humans; Male; Osteoarthritis; Rheumatic Nodule | 2014 |
GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.
Topics: Age Factors; Aged; Colchicine; Cross-Sectional Studies; Disease Management; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; France; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Kidney Function Tests; Male; Maximum Tolerated Dose; Middle Aged; Patient Safety; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2016 |
Is plasmapheresis a potential treatment for familial Mediterranean fever patients resistant or intolerant to colchicine?
Topics: Adolescent; Colchicine; Disease Progression; Drug Resistance; Familial Mediterranean Fever; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasmapheresis; Treatment Outcome | 2017 |
[A case of colchicine overdose progressing to death rapidly].
Topics: Adult; Behcet Syndrome; Bipolar Disorder; Colchicine; Disease Progression; Drug Overdose; Fatal Outcome; Female; Humans; Suicide; Time Factors | 2015 |
Severe deformans tophaceous gouty arthritis.
Topics: Allopurinol; Arthritis, Gouty; Colchicine; Disease Progression; Hand; Humans; Joint Deformities, Acquired; Male; Middle Aged; Prognosis; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Failure | 2017 |
Inhibition of microtubule dynamics impedes repair of kidney ischemia/reperfusion injury and increases fibrosis.
Topics: Acetylation; Animals; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Colchicine; Disease Progression; Epithelial Cells; Fibrosis; Kidney; Macrophages; Male; Mice; Microtubules; Monocytes; Paclitaxel; Phosphorylation; RAW 264.7 Cells; Reperfusion Injury; Tubulin; Wound Healing | 2016 |
Generalized annular granuloma associated with crowned dens syndrome, which resolved with colchicine treatment.
Topics: Chondrocalcinosis; Colchicine; Disease Progression; Female; Gout Suppressants; Granuloma; Granuloma Annulare; Humans; Middle Aged; Neck Pain; Skin Diseases; Synovial Fluid; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Does long term colchicine prevent degradation of collagen fiber network in osteoarthritis?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antirheumatic Agents; Biomarkers; Cartilage Oligomeric Matrix Protein; Colchicine; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Fibrillar Collagens; Humans; Osteoarthritis; Proteolysis; Time Factors; Treatment Outcome | 2018 |
Pronounced linear calcinosis in a boy with mild dermatomyositis. A further possible example of superimposed segmental manifestation of a polygenic disorder.
Topics: Biopsy, Needle; Calcinosis; Child; Colchicine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Immunohistochemistry; Male; Risk Assessment; Severity of Illness Index; Skin Diseases, Genetic; Treatment Outcome | 2009 |
Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Colchicine; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Methotrexate; Treatment Failure; Ursodeoxycholic Acid | 2010 |
The current state of care in gout: Addressing the need for better understanding of an ancient disease.
Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Chronic Disease; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Patient Education as Topic; Quality of Life; Risk Factors; Thiazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2010 |
Rapidly growing aortic arch aneurysm in Behcet's disease.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Thoracic; Aortography; Behcet Syndrome; Blood Vessel Prosthesis Implantation; Colchicine; Disease Progression; Humans; Male; Middle Aged; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Vitamin D status in patients with Behcet's Disease.
Topics: Adolescent; Adult; Alkaline Phosphatase; Behcet Syndrome; Biomarkers; Blood Sedimentation; C-Reactive Protein; Calcium; Case-Control Studies; Colchicine; Disease Progression; Female; Humans; Male; Middle Aged; Phosphates; Vitamin D; Young Adult | 2011 |
Diagnosis. Severity scoring system for paediatric FMF.
Topics: Age of Onset; Child; Child, Preschool; Colchicine; Comorbidity; Disease Progression; Erysipelas; Familial Mediterranean Fever; Humans; Pleurisy; Prognosis; Severity of Illness Index | 2012 |
Familial Mediterranean fever in siblings.
Topics: Adolescent; Amyloidosis; Child; Child, Preschool; Colchicine; Cytoskeletal Proteins; Disease Progression; Dose-Response Relationship, Drug; Familial Mediterranean Fever; Female; Humans; Incidence; Infant; Male; Mutation; Pyrin; Risk Factors; Severity of Illness Index; Siblings; Time Factors; Young Adult | 2012 |
Development of amyloidosis in Behçet's syndrome with isolated mucocutaneous involvement.
Topics: Adult; Amyloidosis; Behcet Syndrome; Biopsy; Colchicine; Disease Progression; Humans; Kidney; Male; Mucous Membrane; Prognosis; Sex Factors; Skin; Treatment Outcome | 2004 |
The burden of amyloidosis on the gastrointestinal tract of an ankylosing spondylitis patient.
Topics: Adult; Amyloidosis; Biopsy, Needle; Colchicine; Colonoscopy; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Gastrointestinal Diseases; Humans; Immunohistochemistry; Male; Melphalan; Risk Assessment; Spondylitis, Ankylosing | 2003 |
Sustained, progressive, nonresolving abdominal pain: a previously undescribed clinical presentation of familial Mediterranean fever.
Topics: Abdominal Pain; Acute-Phase Proteins; Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Disease Progression; Familial Mediterranean Fever; Fever; Humans; Male; Retreatment; Treatment Failure; Treatment Outcome | 2006 |
Clinical study of 7 cases of familial Mediterranean fever with MEFV gene mutation.
Topics: Abdominal Pain; Adult; Base Sequence; C-Reactive Protein; Chest Pain; Colchicine; Cytoskeletal Proteins; Disease Progression; Drug Administration Schedule; Familial Mediterranean Fever; Female; Humans; Leukocytosis; Male; Middle Aged; Mutation; Pleural Effusion; Pyrin; Radiography, Thoracic; Tomography, X-Ray Computed | 2007 |
Is Familial Mediterranean Fever a thrombotic disease or not?
Topics: Adolescent; Adult; Analysis of Variance; Biomarkers; Case-Control Studies; Child; Child, Preschool; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Humans; Infant; Male; Severity of Illness Index; Statistics, Nonparametric; Thrombosis | 2008 |
Familial linear scleroderma (en coup de sabre) responsive to antimalarials and narrowband ultraviolet B therapy.
Topics: Adult; Antimalarials; Chloroquine; Colchicine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Forehead; Genetic Predisposition to Disease; Gout Suppressants; Humans; Scleroderma, Localized; Ultraviolet Therapy | 2007 |
[Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Cartilage, Articular; Chondrocalcinosis; Colchicine; Diagnosis, Differential; Disease Progression; Glucocorticoids; Gout Suppressants; Humans; Injections, Intra-Articular; Interleukin-1beta; Methotrexate; Middle Aged; Risk Factors; Synovial Membrane | 2007 |
Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
Topics: Adrenal Cortex Hormones; Adult; Age of Onset; Behcet Syndrome; Colchicine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Severity of Illness Index; Taiwan; Treatment Outcome; Uveitis | 2008 |
Colchicine and the progression of experimental renal fibrosis.
Topics: Animals; Colchicine; Disease Progression; Fibrosis; Glomerulosclerosis, Focal Segmental; Gout Suppressants; Kidney; Kidney Failure, Chronic; Male; Rats; Rats, Wistar | 1996 |
Severe amyloidosis with mild multiple myeloma--an unusual course.
Topics: Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Colchicine; Disease Progression; Fatal Outcome; Female; Heart Failure; Humans; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Prednisone | 2000 |
Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever.
Topics: Age of Onset; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Genotype; Humans; Male; Phenotype; Sex Factors | 2000 |
[Immunological indices in development of periodic disease].
Topics: Adolescent; Adult; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Gout Suppressants; Humans; Immunity, Cellular; Lymphocyte Activation; Male; Middle Aged; Prognosis; T-Lymphocytes | 2000 |
Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Behcet Syndrome; Case-Control Studies; Colchicine; Disease Progression; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prednisone; Prolactin; Reference Values; Severity of Illness Index; Time Factors | 2001 |